A new trading day began on Friday, with Dexcom Inc (NASDAQ: DXCM) stock price down -0.14% from the previous day of trading, before settling in for the closing price of $78.10. DXCM’s price has ranged from $62.34 to $142.00 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 28.80% over the last five years. Meanwhile, its annual earnings per share averaged 12.32%. With a float of $385.55 million, this company’s outstanding shares have now reached $390.60 million.
The firm has a total of 9600 workers. Let’s measure their productivity. In terms of profitability, gross margin is 61.68%, operating margin of 15.88%, and the pretax margin is 18.81%.
Dexcom Inc (DXCM) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of Dexcom Inc is 1.29%, while institutional ownership is 93.17%. The most recent insider transaction that took place on Nov 20 ’24, was worth 318,275. In this transaction EVP, Chief HR Officer of this company sold 4,259 shares at a rate of $74.73, taking the stock ownership to the 71,192 shares. Before that another transaction happened on Nov 15 ’24, when Company’s EVP, Chief Financal Officer sold 3,500 for $75.51, making the entire transaction worth $264,285. This insider now owns 80,774 shares in total.
Dexcom Inc (DXCM) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 12.32% per share during the next fiscal year.
Dexcom Inc (NASDAQ: DXCM) Trading Performance Indicators
Here are Dexcom Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.12. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.69. Likewise, its price to free cash flow for the trailing twelve months is 56.86.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.67, a number that is poised to hit 0.52 in the next quarter and is forecasted to reach 2.03 in one year’s time.
Technical Analysis of Dexcom Inc (DXCM)
Analysing the last 5-days average volume posted by the [Dexcom Inc, DXCM], we can find that recorded value of 3.76 million was lower than the volume posted last year of 3.92 million. As of the previous 9 days, the stock’s Stochastic %D was 80.83%. Additionally, its Average True Range was 2.48.
During the past 100 days, Dexcom Inc’s (DXCM) raw stochastic average was set at 28.53%, which indicates a significant decrease from 86.31% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 40.85% in the past 14 days, which was lower than the 91.05% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $71.23, while its 200-day Moving Average is $100.61. Now, the first resistance to watch is $78.94. This is followed by the second major resistance level at $79.90. The third major resistance level sits at $80.42. If the price goes on to break the first support level at $77.46, it is likely to go to the next support level at $76.94. Should the price break the second support level, the third support level stands at $75.98.
Dexcom Inc (NASDAQ: DXCM) Key Stats
With a market capitalization of 30.42 billion, the company has a total of 390,595K Shares Outstanding. Currently, annual sales are 3,622 M while annual income is 541,500 K. The company’s previous quarter sales were 994,200 K while its latest quarter income was 134,600 K.
